Oncology Fellows Underestimate Workload, Report High Burnout

Share this content:
Oncology fellows may underestimate future workload of actual practice.
Oncology fellows may underestimate future workload of actual practice.

U.S. oncology fellows may underestimate the workload they will experience once they enter practice, according to research published online in the Journal of Clinical Oncology.

Tait D. Shanafelt, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues conducted a postexamination survey among U.S. oncology fellows taking the 2013 Medical Oncology In-Training Examination (MedOnc ITE). The authors sought to assess fellows' career plans, professional expectations, burnout, quality of life (QOL), fatigue, and satisfaction with work-life balance (WLB).

RELATED: Despite High Job Satisfaction, Oncologists Report Burnout

The researchers found that, of the 1,345 respondents, frequency of burnout among fellows overall was similar to that of practicing oncologists. Practicing oncologists reported lower fatigue (P < 0.001) and better overall QOL scores (P < 0.001) than fellows, but were less satisfied with WLB (P = 0.0031) and specialty choice (P < 0.001). 

Regarding future work hours, fellows' expectations were five to six hours per week fewer than oncologists' actual reported work hours. ITE scores were inversely associated with levels of burnout (P = 0.02) and educational debt (P ≤ 0.004).

"Unrealized expectations regarding work hours may contribute to future professional dissatisfaction, burnout, and challenges with WLB," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

  1. Shanafelt, Tait D. et al. "Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into?" doi: 10.1200/JCO.2014.56.2827. July 21, 2014.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs